웨스트버지니아의 비소세포폐암 임상 시험
비소세포폐암 관련 연구 14개가 웨스트버지니아 내 여러 지역에서 참여자를 모집하고 있습니다.
웨스트버지니아의 도시
공식 연구 텍스트(영어)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- United Hospital Center, Bridgeport
- Edwards Comprehensive Cancer Center, Huntington
- West Virginia University Healthcare, Morgantown
- 외 2개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT04267848A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
- West Virginia University ( Site 3237), Morgantown
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT07513376Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- Edwards Comprehensive Cancer Center, Huntington
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT06498635A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
- Charleston Area Medical Center (CAMC), Charleston
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07361510A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
- Research Site, Charleston
- Research Site, Morgantown
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06868277Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
- West Virginia University Hospitals - Mary Babb Randolph Cancer Center, Morgantown
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06712316Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
- Research Site, Morgantown
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT07291037Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
- Edwards Comprehensive Cancer Center, Huntington
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 6. 3. 업데이트됨 · NCT05642572Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
- Edwards Comprehensive Cancer Center, Huntington
- West Virginia University Healthcare, Morgantown
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 5. 6. 업데이트됨 · NCT06116682Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
- Edwards Comprehensive Cancer Center, Huntington
- West Virginia University Healthcare, Morgantown
피험자 모집 중2상
18 Minutes · 모든 성별 · 2026. 5. 5. 업데이트됨 · NCT06031688Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- United Hospital Center, Bridgeport
- Edwards Comprehensive Cancer Center, Huntington
- WVUH-Berkely Medical Center, Martinsburg
- 외 3개
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 5. 5. 업데이트됨 · NCT06616584Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Edwards Comprehensive Cancer Center, Huntington
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 3. 17. 업데이트됨 · NCT06418204SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Morgantown
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774Analysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers
- West Virginia University, Morgantown
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2024. 11. 29. 업데이트됨 · NCT06626243ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.